Clinical trial

The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.

NCT02618538

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record below.

Study at a glance

Registry-backed

The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-07-01

PhaseN/A

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Sponsors & collaborators

Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemontelead sponsor

Azienda Sanitaria Locale Biellacollaborator

Azienda Sanitaria Locale di Vercellicollaborator

Fondazione Edo Ed Elvo Tempia Valentacollaborator

Associazione Italiana per la Ricerca sul Cancrocollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02618538 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.